Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
88,000
Employees88,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
88,000
Employees88,000

PFE Key Statistics

Market cap
142.72B
Market cap142.72B
Price-Earnings ratio
69.96
Price-Earnings ratio69.96
Dividend yield
6.28%
Dividend yield6.28%
Average volume
34.29M
Average volume34.29M
High today
$26.43
High today$26.43
Low today
$25.25
Low today$25.25
Open price
$26.21
Open price$26.21
Volume
47.66M
Volume47.66M
52 Week high
$40.37
52 Week high$40.37
52 Week low
$25.23
52 Week low$25.23

PFE News

Benzinga 7h
What's Going On With Pfizer Stock On Thursday? - GSK, Pfizer - Benzinga

Loading... Loading... GSK Plc GSK has reportedly taken legal action against Pfizer Inc PFE and BioNTech SE BNTX in a Delaware federal court, alleging patent in...

What's Going On With Pfizer Stock On Thursday? - GSK, Pfizer - Benzinga
Seeking Alpha 10h
GSK sues Pfizer, BioNTech over COVID-19 vaccines patents

GSK (NYSE:GSK) is reportedly suing Pfizer (PFE) and partner BioNTech (BNTX) for patent infringement over the use of certain mRNA technology for their COVID-19 C...

GSK sues Pfizer, BioNTech over COVID-19 vaccines patents
Seeking Alpha 12h
Dividend Harvesting Portfolio Week 164: $16400 Allocated, $1466.94 Projected Dividends - Seeking Alpha

PM Images It feels like it's one thing after another as instability in the Middle East continues, the probability of a rate cut in May continues to decrease, a...

Dividend Harvesting Portfolio Week 164: $16400 Allocated, $1466.94 Projected Dividends - Seeking Alpha

Analyst ratings

64%

of 25 ratings
Buy
36%
Hold
64%
Sell
0%

More PFE News

Yahoo Finance 1d
Pfizer Declares Second-Quarter 2024 Dividend - Yahoo Finance

Board of Directors approves quarterly cash dividend of $0.42 per share NEW YORK, April 24, 2024--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that...

Pfizer Declares Second-Quarter 2024 Dividend - Yahoo Finance
Investor's Business Daily 1d
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?

Pfizer (PFE) stock is trading near an 11-year low as the drugmaker looks for its next big break after developing the first Covid vaccine with Germany's BioNTech...

Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Yahoo Finance 1d
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold? - Yahoo Finance

The healthcare sector has gained momentum lately on investors’ rush to safety in a volatile stock market. The sector is non-cyclical in nature, which, in turn,...

Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold? - Yahoo Finance
Yahoo Finance 1d
Analysts Estimate Pfizer to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

The market expects Pfizer (PFE) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2024. This...

Analysts Estimate Pfizer to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Yahoo Finance 2d
Weight Loss Drugs Market Trends Analysis 2018-2023 and Opportunities Forecast 2024-2033 Featuring Pfizer, Roche ... - Yahoo Finance

Company Logo Global Weight Loss Drugs Market Global Weight Loss Drugs Market Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss Drugs Global Market...

Weight Loss Drugs Market Trends Analysis 2018-2023 and Opportunities Forecast 2024-2033 Featuring Pfizer, Roche ... - Yahoo Finance
Benzinga 2d
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown

Loading... Loading... Moderna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London patent trial concerning the development o...

Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
Yahoo Finance 2d
Better Buy: Pfizer vs. Viking Therapeutics - Yahoo Finance

The pharmaceutical industry has been a whirlwind of highs and lows for investors over the past two decades. The high-risk, high-reward nature of drug developmen...

Better Buy: Pfizer vs. Viking Therapeutics - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.